SEC Company Response from InspireMD, Inc. (NSPR) (CIK 0001433607) (NSPR) — Mar 6, 2017
InspireMD, Inc. (NSPR) (CIK 0001433607)
Date: March 6, 2017 · CIK: 0001433607 · Accession: 0001493152-17-002158
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-215682
Letter
InspireMD, Inc.
Menorat Hamaor St.
Tel Aviv, Israel 6744832
March 6, 2017
VIA EDGAR
Division of Corporation Finance
Securities and Exchange Commission
Washington, D.C. 20549
Attention:
Ms. Heather Percival
Mr. Geoff Kruczek
Ms. Amanda Ravitz
Re:
InspireMD, Inc.
Registration Statement on Form S-1, originally filed on January 24, 2017
File No. 333-215682, as amended (the “Registration Statement”)
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, InspireMD, Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective at 4:00 p.m., Eastern Time, on March 8, 2017, or as soon thereafter as practicable.
In connection with the Company’s request for acceleration of the effective date of the Registration Statement, the Company acknowledges the following:
● should the U.S. Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
● the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
● the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Rick A. Werner, Esq. at (212) 659-4974.
Very
truly yours,
InspireMD,
Inc.
Show Raw Text
CORRESP
1
filename1.htm
InspireMD,
Inc.
4
Menorat Hamaor St.
Tel
Aviv, Israel 6744832
March
6, 2017
VIA
EDGAR
Division
of Corporation Finance
Securities and Exchange Commission
Washington, D.C. 20549
Attention:
Ms. Heather Percival
Mr. Geoff Kruczek
Ms. Amanda Ravitz
Re:
InspireMD, Inc.
Registration Statement
on Form S-1, originally filed on January 24, 2017
File No. 333-215682,
as amended (the “Registration Statement”)
Ladies
and Gentlemen:
Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as amended, InspireMD, Inc. (the “Company”)
hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective
at 4:00 p.m., Eastern Time, on March 8, 2017, or as soon thereafter as practicable.
In
connection with the Company’s request for acceleration of the effective date of the Registration Statement, the Company
acknowledges the following:
●
should the U.S.
Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated
authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
●
the action of the
Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company
from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
●
the Company may
not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission
or any person under the federal securities laws of the United States.
Should
any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel,
Haynes and Boone, LLP, attention: Rick A. Werner, Esq. at (212) 659-4974.
Very
truly yours,
InspireMD,
Inc.
By:
/s/
Craig Shore
Craig Shore
Chief Financial
Officer